CHINA – The Chinese unit of German medical technology company Siemens Healthineers has unveiled a new strategy that aims to entirely localize its production in the Asian country.

Siemens Healthineers China will strive to make all its products in China and deepen its innovative research and development based on the market’s needs, the firm has announced, adding that it will contribute to the country’s ‘Healthy China’ agenda as a “Chinese company.”

With huge commercial potential and a unique market environment, China has always had great strategic importance to Siemens Healthineers, Elisabeth Staudinger, board member and Asia Pacific regional head, was quoted by the news agency Yicai Global.

With 80 percent of Siemens Healthineers China’s products already made in the country, the company will gradually increase that.

Jerry Wang, President -Siemens Healthineers China


The firm also said in a press release that the laboratory diagnostics plant that finished construction in Shanghai at the end of last year will become Siemens Healthineers’ first in vitro diagnostic reagent production base in the Asia Pacific.

It will mostly produce immune reagents. Its R&D center project is also being advanced, the statement said.

Shanghai and Shenzhen are key manufacturing and export bases for Siemens Healthineers China, Staudinger said.

Besides serving the Chinese market, the two factories there also export over half of the company’s medical devices output, she added, noting that both have restarted production.

Since Siemens Shanghai Medical Equipment restarted operations after the Covid-19 outbreak in the city, 500 staff returned to work at the plant, completing orders through hard work, Kong Jun, vice president and general manager.

Siemens Healthineers’ Magnetom Terra, the first 7-Tesla magnetic resonance imaging scanner for clinical use, was approved by China’s National Medical Products Administration (NMPA) on 8 June, 2022.

These approvals qualify it as the world’s first ultra-high field technology device approved by the NMPA and the US Food and Drug Administration, and with CE certification.

Meanwhile, Siemens Healthineers recently inaugurated the new production line at India’s Bengaluru facility to manufacture computed tomography scanners under the production-linked initiative (PLI) scheme and launched MAGNETOM Free.Star, a disruptively simple approach to MRI that transforms access to high-value care.

MAGNETOM Free.Star belongs to the new generation of scanners from Siemens Healthineers based on revolutionary High-V MRI Platform.  

It is built on the latest DryCool technology, it is a virtually helium-free scanner with an ultra-compact footprint that is far easier to install. 

Based on the revolutionary direct signal conversion of its QuantaMax detector, NAEOTOM Alpha offers high-resolution images at minimal dose, spectral information in every scan, and improved contrast at lower noise.

Photon-counting CT will advance medical diagnostics towards precise, non-invasive diagnosis in cardiology, pulmonology, oncology, and emergency medicine.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE